A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
Clinical trial NCT02452632 · COMPLETED
Trial details
- NCT number
- NCT02452632
- Sponsor
- Astellas Pharma Korea, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-22
- Primary completion
- 2017-01-05
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.